Cystic Fibrosis Gene Therapy Consortium secures Efficacy and Mechanism Evaluation (EME) funding for Multidose Clinical Trial
Multi-Dose Clinical Trial Funding
Professor Eric Alton, chief investigator, said: "Our application for EME funding required an intensive effort by many members of the Consortium. It was rigorously peer-reviewed, and our success in being awarded the grant is a strong endorsement of both our non-viral gene therapy programme and the clinical trial design. With funding for this key part of the Consortium's programme secure, we will begin preparations for the trial immediately. We would like to thank the EME board for its confidence in us, and also all of those whose support has reinforced our determination to continue the programme for the benefit of CF patients."
Information for Patients on Our Clinical Trial
Consortium Members' Internal Website
Medical Futures Innovation Award 2011